Literature DB >> 1049242

On the role of storage granules in the functional utilization of newly synthesized dopamine.

P A Shore.   

Abstract

Previous studies have provided evidence for the prime importance of newly synthesized dopamine as compared with the large endogenous stores of amine in the functional mobilization of dopamine under conditions of a heavy demand on the neuron such as in the presence of a neuroleptic. The present study was designed to examine the role of storage granules in the utilization of newly synthesized dopamine and to examine the mechanism of the cataleptic action of reserpine-like drugs. It was found that the injection of a small dose of L-Dopa did not reverse the catalepsy produced by the short-acting dopamine depleter, Ro 4-1284, either when the depleter was given alone or was given after tyrosine hydroxylase blockade by alpha-methyltyrosine, provided that the L-Dopa was given at a time when Ro 4-1284 was present. However, the same dose of L-Dopa quickly reversed catalepsy when given at a time of dopamine depletion but in the absence of Ro 4-1284. Since alpha-methyltyrosine alone does not produce catalepsy until exhaustion of the large endogenous dopamine pool, but quickly potentiates neuroleptic-induced catalepsy, it is suggested that under normal conditions the slow transfer of stored dopamine to a releasable site is sufficiently rapid to maintain striatal function. However, the transfer rate appears to be too slow for adequate mobilization of the store under conditions of a heavy demand. It is further suggested that a prime role of storage granules is to channel newly synthesized dopamine into the synaptic cleft. Reserpine-like drugs appear to produce catalepsy, not by depletion per se of the main dopamine pool, but by interference with this granule channeling function.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1049242     DOI: 10.1007/bf01248771

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  12 in total

1.  On a prime role for newly synthesized dopamine in striatal function.

Authors:  P A Shore; R L Dorris
Journal:  Eur J Pharmacol       Date:  1975-02       Impact factor: 4.432

2.  THE EFFECT OF PRENYLAMINE ON THE METABOLISM OF CATECHOL AMINES AND 5-HYDROXYTRYPTAMINE IN BRAIN AND ADRENAL MEDULLA.

Authors:  A V JUORIO; M VOGT
Journal:  Br J Pharmacol Chemother       Date:  1965-04

3.  3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists.

Authors:  A CARLSSON; M LINDQVIST; T MAGNUSSON
Journal:  Nature       Date:  1957-11-30       Impact factor: 49.962

4.  Evidence for a prime role of newly synthesized dopamine in mesolimbic dopamine areas.

Authors:  E S Sears; P A Shore
Journal:  J Pharm Pharmacol       Date:  1975-09       Impact factor: 3.765

5.  Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats.

Authors:  I Kuruma; G Bartholini; R Tissot; A Fletscher
Journal:  J Pharm Pharmacol       Date:  1972-04       Impact factor: 3.765

6.  On the mode of action of reserpine on dopamine metabolism in the rat striatum.

Authors:  H C Guldberg; O J Broch
Journal:  Eur J Pharmacol       Date:  1971-01       Impact factor: 4.432

7.  Effects of benzoquinolizines and ring-substituted aralkylamines on serotonin metabolism.

Authors:  A Pletscher; M Da Prada; W P Burkard; J P Tranzer
Journal:  Adv Pharmacol       Date:  1968

8.  Effects of clozapine on cerebral catecholaminergic neurone systems.

Authors:  G Bartholini; W Haefely; M Jalfre; H H Keller; A Pletscher
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

9.  In vivo continuous estimation of 3 H-dopamine synthesis and release in the cat caudate nucleus. Effects of -methyl-p-tyrosine and of transection of the nigro neostriatal pathway.

Authors:  M J Besson; A Cheramy; C Gauchy; J Glowinski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

10.  Biochemical and pharmacological studies of RO 1-9569 (tetrabenazine), a nonindole tranquilizing agent with reserpine-like effects.

Authors:  G P QUINN; P A SHORE; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1959-10       Impact factor: 4.030

View more
  2 in total

1.  Proceedings of the British Pharmacological Society. Liverpool, 6th-8th April, 1988. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

2.  Comparative neuropharmacology of buspirone and MJ-13805, a potential anti-anxiety drug.

Authors:  B A McMillen; L A Mattiace
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.